MDC innovations are available for exclusive or non-exclusive licensing across therapeutic domains. Select a compound, review its summary, and submit an interest form to initiate discussion.
Optimized for enhanced viral protein affinity and oral bioavailability. Preclinical insights support potential in respiratory and cytoplasmic-targeted viruses.
Submit Licensing InterestROS-responsive agent with anti-inflammatory properties and metal-assisted delivery timing. Target: oxidative stress conditions in neurodegenerative pathways.
Submit Licensing InterestDesigned for selective tumor activation in acidic microenvironments. Enables logic-gated toxicity with metal-mediated stability.
Submit Licensing InterestMDC for neuroprotection, axonal regeneration, and trauma-targeted delivery. Currently under evaluation for spinal cord injury support.
Submit Licensing Interest